Literature DB >> 35451416

Hybrid surgery techniques for the treatment of in-stent restenosis after 5 years of femoral artery self-expanding bare-metal stent implantation: A case report.

Jianguo Zhou1, Guosong Zha, Guosheng Qian.   

Abstract

RATIONALE: Lower extremity arteriosclerosis obliterans (ASO) disease is caused by the formation of atherosclerotic plaque in the femoral artery, which causes the stenosis and occlusion of lower legs, and then leads to chronic limb ischemia. Stent intervention is the most common treatment for ASO in the lower extremities, although there is a risk of overstretching or fracturing the stent, resulting in stent rupture. We provide a unique method for treating stent rupture. PATIENT CONCERNS: A 79-year-old male presented with intermittent claudication of the left lower limb for 6 months. Five years ago, a stent was placed in the lower extremity femoral artery. According to the examination, the stent suffered a modest torsional fracture. DIAGNOSIS: The case was diagnosed with lower extremity ASO.
INTERVENTIONS: We performed a combination of femoral endarterectomy and interventional surgery. OUTCOMES: Blood flow was restored after the hybrid operation has been used to treat arterial stenosis in the lower limbs.
CONCLUSION: Integrating vascular interventional surgeries can shorten surgical procedures time and increase success rates.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35451416      PMCID: PMC8913107          DOI: 10.1097/MD.0000000000029042

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Arteriosclerosis obliterans of the lower limbs are becoming more common as society's overall lifestyles improve and the population ages. Vascular stents have long been the prefered treatment for lower limb arteriosclerosis because of their excellent therapeutic efficiency and little surgical trauma. While vascular stenting has been successfully implanted, postoperative complications have always been a significant issue, compromising the therapeutic efficacy and posing a direct threat to patients’ lives. Endovascular therapy has become a standard treatment for peripheral artery disease. When compared to typical percutaneous endovascular angioplasty, self-inflating metal stent insertion considerably boosted the femoral artery patency rate.[ Restenosis within the stent, on the other hand, is a well-known complication following stent placement.[ In-stent restenosis, which leads to stent re-occlusion, has long been recognized as one of the most prevalent causes of postoperative complications.[ The current research on the management of in-stent restenosis is discordant. This paper describes a case of stent obstruction caused by in-stent restenosis and treated utilizing hybrid surgical techniques.

Case presentation

Patient data: A 79-year-old male patient had intermittent claudication of the left lower limb for about 6 months, with a claudication distance of about 30 cm. Five years ago, the patients had a femoral artery stenting of the left lower leg stent implantation. According to a contrast-enhanced CT scan of the ischemic zone, the preceding stent had a local torsion fracture, which caused the claudication (Fig. 1A). In the risk factors assessment, the patient also had hypertension.
Figure 1

(A) Preoperative contrast-enhanced CT scan image and 3D reconstruction of the femoral artery of the lower extremity. (B) In-stent restenosis visible from intraoperative angiography. (C) Intraoperative angiography of the left side of the external iliac artery, femoral artery and femoral artery occlusion (red arrow). (D) The stenosis and rupture of the femoral artery stent may be seen once the femoral artery has been exposed.

(A) Preoperative contrast-enhanced CT scan image and 3D reconstruction of the femoral artery of the lower extremity. (B) In-stent restenosis visible from intraoperative angiography. (C) Intraoperative angiography of the left side of the external iliac artery, femoral artery and femoral artery occlusion (red arrow). (D) The stenosis and rupture of the femoral artery stent may be seen once the femoral artery has been exposed. Surgical treatment: Anesthesiologist administering general anesthesia to the patient after endotracheal intubation. Puncture from the right femoral artery through the right common iliac artery to the left common iliac artery, and in-stent restenosis visible from first intraoperative angiography (Fig. 1B). Then Intraoperative angiography of the left side of the external iliac artery, femoral artery and femoral artery occlusion, and deep arterial patency (Fig. 1C). Proximal openings in the original stents, we block blood flow by 7 ∗ 60 ARMADA balloon. After the lumen was blocked, the left leg segment was incised, and exposed the femoral artery as well as the surrounding either deep or shallow artery were also exposed. After incising open the left femoral artery, we discovered that the previous stent was twisted and fractured (Fig. 1D). The twisted stent was then removed, followed by the tunica intima being stripped. After the distal end of the original stent was expanded with a biliary tract probe, the guide wire was sent to the distal end of the preceding stent, and the blood vessel wall of the left femoral artery was sutured. When the balloon was withdrawn to clear the blockage, there was no bleeding at the incision site of the left femoral artery. Through the blockage of the original stent and the distal end of the stent, a guided wire catheter was utilized to enter the popliteal artery. After determining the exact lumen, the 4∗150 mm and 5∗150 mm Mustang balloons were used to dilate the external iliac artery's occluded vascular segment, followed by 7∗60 mm ARMADA balloons to entirely dilate the occlusion segment. Finally, a MUSTANG balloon with a diameter of 5∗150 mm was employed to widen the vessel's superficial section (adjacent to the original stent). The outcome of this angiographic was excellent. After the operation, dual anti-platelets (Aspirin & Polyvir) and vasodilator (Kaina) were given. One month after the procedure, blood flow was unobstructed at the location where the original stent was removed, and local stenosis was detected at the place where the prior stent was removed. Three months following surgery, the stent was completely blocked underneath the previous stent's placement, and blood flow in the stent's distal popliteal artery was adequate. Secondary surgical treatment: Angiography under local anaesthetic revealed that the left iliac artery, common femoral artery, and deep femoral artery all had continuous blood flow. On the other hand, the new stent distal to the old stent was completely obstructed. The blood flow through the popliteal artery was continuous at the stent's distal end. The balloon section, which was roughly 5∗300 mm in diameter, was checked, and the angiographic result showed that blood flow was still present. According to a contrast-enhanced CT scan of the lower limb arteries 1.5 months after the surgery, blood flow in the lower limb arteries remained constant. Outcome and follow-up: At 1 month, 3 months, and 1 year after surgery, we used a contrast-enhanced CT scan and 3D reconstruction to analyse the patient's improvement (Fig. 2A, B&C). The femoral arteries showed no signs of stenosis, indicating that the treatment was effective.
Figure 2

C D&E The post-operative CT images at 1 month, 3 months, and 1 year after dual surgeries, the results of successful cannulation at the lower extremity arteries.

C D&E The post-operative CT images at 1 month, 3 months, and 1 year after dual surgeries, the results of successful cannulation at the lower extremity arteries.

Discussion

Lower limb artery stenting is a conventional therapy for peripheral arteria disease that has been shown to have a greater long-term patency rate than traditional percutaneous transluminal angioplasty. However, stent rupture is a common complication following stenting of the lower leg artery. According to Jaff et al., stent rupture in the superficial femoral artery may be categorized into 5 subtypes.[ A Type I stent rupture involves just 1 stent. A Type II stent rupture involves many stents rupturing in diverse sites. In Type III, a series of stent fractures culminated in a complete transverse fracture with no displacement. A Type IV stent rupture resulted in a complete transverse fracture with stent displacement, and Type V was a spiral fracture, also known as torsion fracture. Stent rupture can result in catastrophic modifications in the target vasculature and is a common cause of in-stent restenosis (ISR), particularly in lengthy segments where pseudoaneurysms might form.[ ISR refers to the narrowing of the luminal caliber of the stent owing to the development of stenosis inside the stent itself. ISR should be differentiated from stent compression. The treatment options available at present include balloon angioplasty (hyperdilation or isodilation), laser ablation, atherectomy, and Z-stent placement.[ There is no common protocol for the treatment of ISR following the implantation of a peripheral arterial disease stent in the lower extremities. For certain ISRs that aren’t too severe, complete endovascular therapy may be an option.[ However, severe and serious ISRs require open bypass surgery, which includes a substantial portion of surgical trauma.[ When our initial attempt at endovascular therapy failed, we turned to open surgery in combination with endovascular treatment. This method not only expedites the treatment but also resolves complicated endovascular interventions and improves the success rate of the operation. In an endovascular combined open surgery, our experience indicates that vascular mesh and artificial vessels should be prepared prior to operation. When suturing the leftover vascular membrane after stent removal is problematic, vascular mesh or artificial vessels may be used to avoid artery stenosis at the stitching segment. Drug-coated balloons for occlusive stents may be more beneficial in the long run than conventional balloons, although they are more costly.[

Author contributions

Conceptualization: Jianguo Zhou. Data curation: Guosheng Qian& Guosong Zha Formal analysis: Jianguo Zhou. Methodology: Jianguo Zhou. Resources: Jianguo Zhou. Writing – original draft: Jianguo Zhou. Writing – review & editing: Jianguo Zhou.
  13 in total

1.  Coronary stent fracture: the hidden truth of a problem more common than stent thrombosis.

Authors:  John D Carroll
Journal:  Catheter Cardiovasc Interv       Date:  2009-01-01       Impact factor: 2.692

2.  Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up.

Authors:  Herbert F Lugmayr; Hermann Holzer; Manfred Kastner; Harald Riedelsberger; Alexandra Auterith
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

3.  A case complicated by floating fractured stent 141 months after nitinol stent implantation in the superficial femoral artery.

Authors:  Takuya Tsujimura; Takayuki Ishihara; Osamu Iida; Masashi Fujita; Shin Okamoto; Masaaki Uematsu
Journal:  J Cardiol Cases       Date:  2017-04-29

4.  Stent fractures after superficial femoral artery stenting.

Authors:  Jae Young Park; Yong Sun Jeon; Soon Gu Cho; Chan Ik Jin; Kyung Rae Kim; Woo Young Shin; Jang Yong Kim; Kee Chun Hong
Journal:  J Korean Surg Soc       Date:  2012-08-27

5.  Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.

Authors:  Salvatore Cassese; Gjin Ndrepepa; Sebastian Kufner; Robert A Byrne; Daniele Giacoppo; Ilka Ott; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati; Massimiliano Fusaro
Journal:  EuroIntervention       Date:  2017-07-20       Impact factor: 6.534

Review 6.  An overview of in-stent restenosis in iliofemoral venous stents.

Authors:  Taimur Saleem; Seshadri Raju
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2021-11-11

7.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors:  Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

Review 8.  Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices.

Authors:  Michael Jaff; Michael Dake; Jeffrey Pompa; Gary Ansel; Tony Yoder
Journal:  Catheter Cardiovasc Interv       Date:  2007-09       Impact factor: 2.692

Review 9.  Stent fracture in the superficial femoral and proximal popliteal arteries: literature summary and economic impacts.

Authors:  Nancy Neil
Journal:  Perspect Vasc Surg Endovasc Ther       Date:  2013-11-13

10.  Longitudinal stent fracture 11 months after implantation in the left pulmonary artery and successful management by a stent-in-stent maneuver.

Authors:  Walter Knirsch; Nikolaus A Haas; Martin A G Lewin; Frank Uhlemann
Journal:  Catheter Cardiovasc Interv       Date:  2003-01       Impact factor: 2.692

View more
  1 in total

1.  Efficacy and Safety Differences between Domestic Paclitaxel Drug-Coated Balloons and Metal Bare Stents in the Treatment of ASO of Femoral-Popliteal Arteries Type IIA-C.

Authors:  Fuqing Wei; Fenglei Huang; Fengkui Cui
Journal:  Contrast Media Mol Imaging       Date:  2022-07-06       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.